A comparison of tertiary level nicu costs for infants born <1250 g supplemented with human versus bovine milk-based fortifiers

A comparison of tertiary level nicu costs for infants born <1250 g supplemented with human versus bovine milk-based fortifiers

Play all audios:

Loading...

ABSTRACT BACKGROUND Human milk-based fortifiers (HMBF) are more costly than bovine milk-based fortifiers (BMBF); but, the efficacy of human or bovine fortification for infants born <1250 g has yet to be fully elucidated. Our objective was to determine the effect of fortifier source on tertiary neonatal costs. METHODS Costs associated with tertiary neonatal care, including direct and indirect hospital expenditures, feed-related costs and physician billing were analysed retrospectively for participants of OptiMoM (NCT02137473), a blinded RCT comparing fortifier type for babies born <1250 g. A generalized linear model of cost according to fortifier type was created. RESULTS Mean [95% confidence interval] daily costs per patient, adjusted for birth gestation and weight, was significantly greater in the human than the BMBF group ($3,452 [$3,186 – $3,740] Canadian dollars (CAD) versus $2,451 [$2,257 – $2,662] CAD) respectively, _p_ < 0.0001). CONCLUSION HMBF usage entails additional costs on NICU stay that should be considered with implementation. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS HUMAN MILK-DERIVED FORTIFIERS ARE LINKED WITH FEED EXTENSION DUE TO HYPOGLYCEMIA IN INFANTS <1250 G OR <30 WEEKS: A MATCHED RETROSPECTIVE CHART REVIEW Article 29 March 2023 IMMEDIATE FORTIFICATION OF HUMAN MILK WITH A BOVINE MILK-DERIVED HUMAN MILK FORTIFIER IN VERY LOW BIRTH WEIGHT INFANTS: A RANDOMIZED CLINICAL TRIAL Article Open access 09 May 2024 DONOR HUMAN MILK VERSUS INFANT FORMULA FOR LOW-RISK INFANTS: A SYSTEMATIC REVIEW Article Open access 06 June 2024 DATA AVAILABILITY The datasets generated during and/or analysed during the current study are not publically available due to a risk for breeching patient confidentiality but may be available from the corresponding author on reasonable request. REFERENCES * Parker MG, Stellwagen LM, Noble L, Kim JH, Poindexter BB, Puopolo KM. Section on Breastfeeding, Committee on Nutrition, Committee on Fetus and Newborn. Promoting human milk and breastfeeding for the very low birth weight infant. Pediatrics 2021;148:e2021054272. Article  PubMed  Google Scholar  * Brown JVE, Embleton ND, Harding JE, McGuire W. Multi-nutrient fortification of human milk for preterm infants. Cochrane Database Syst Rev. 2016;5:CD000343. Google Scholar  * Sandhu A, Fast S, Bonnar K, Baier FJ, Narvey M. Human based Human milk fortifier as Rescue Therapy in Very Low Birth Weight Infants Demonstrating Intolerance to Bovine-Based Human Milk Fortifier. Breastfeed Med. 2017;12:570–3. Article  PubMed  PubMed Central  Google Scholar  * Quigley M, Embleton N, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev. 2019;7:CD002971. PubMed  Google Scholar  * Premkumar MH, Pammi M, Suresh G. Human Milk Derived Fortifier versus Bovine Milk Derived Fortifier for Prevention of Morbidity and Mortality in Preterm Neonates. Cochrane Database Syst Rev. 2019;11:CD013145. Google Scholar  * Sullivan S, Schanler RJ, Kim JH, Patel AL, Trawöger R, Kiechl-Kohlendorfer U, et al. An Exclusively Human Milk-Based Diet is Associated with a Lower Rate of Necrotizing Enterocolitis Than a Diet of Human Milk and Bovine-milk Based Products. J Pediatr. 2010;156:562–7. Article  CAS  PubMed  Google Scholar  * Hair AB, Peluso AM, Hawthorne KM, Perez J, Smith DP, Khan JY, et al. Beyond Necrotizing Enterocolitis Prevention: Improving Outcomes with an Exclusive Human Milk-Based Diet. Breastfeed Med. 2016;11:70–5. Article  PubMed  PubMed Central  Google Scholar  * Herrmann K, Carroll K. An Exclusive Human Milk Diet Reduces Necrotizing Enterocolitis. Breastfeed Med. 2014;9:184–90. Article  PubMed  PubMed Central  Google Scholar  * Assad M, Elliot MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36:216–20. Article  CAS  PubMed  Google Scholar  * O’Connor DL, Kiss A, Tomlinson C, Bando N, Bayliss A, Campbell DM, et al. Nutrient enrichment of human milk with human and bovine milk-based fortifiers for infants born weighing <1250 g: a randomized clinical trial. Am J Clin Nutr. 2018;108:108–16. Article  PubMed  Google Scholar  * Ganapathy V, Hay JW, Kim JH. Costs of Necrotizing Enterocolitis and Cost-Effectiveness of Exclusively Human Milk-Based Products in Feeding Extremely Premature Infants. Breastfeed Med. 2011;6:1–9. Google Scholar  * Zupancic JAF, Richardson DK, O’Brien BJ, Schmidt B, Weinstein MC. Daily Cost Prediction Model in Neonatal Intensive Care. Int J Technol Assess Health Care. 2003;19:330–8. Article  PubMed  Google Scholar  * Petrou S, Davidson LL. Economic issues in the follow-up of neonates. Semin Neonatol. 2000;5:159–69. Article  CAS  PubMed  Google Scholar  * Ontario Ministry of Health and Long Term Care. Schedule of Benefits Physician Services under the Health Insurance Act, 2015. Available at: www.health.gov.on.ca/en/pro/programs/ohip/sob. * Trang S, Zupancic JA, Unger S, Kiss A, Bando N, Wong S, et al. Cost-effectiveness of Supplemental Donor Milk Versus Formula for Very Low Birth Weight Infants. Pediatrics. 2018;141:1–10. Article  Google Scholar  * CANSIM table 18-10-0005-01: Consumer price index, annual average, not seasonally adjusted. 2019. Statistics Canada. Available at: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1810000501. * de Souza RJ, Eisen RB, Perera S, Bantoto B, Bawor M, Dennis BB, et al. Best (but oft-forgetten) practices: sensitivity analysis in randomized controlled trials. Am J Clin Nutr. 2016;103:5–17. Article  PubMed  Google Scholar  * SAS statistics for Windows [software], Version 9.4. Cary, NC. SAS Institute; Released 2013. https://documentation.sas.com/doc/en/pgmsascdc/9.4_3.5/whatsnew/titlepage.htm. * R Core Team (2020). R: A language and environment for statistical computing. R Foundation for statistical computing, Vienna, Austria. URL https://www.R-project.org/. * Johnson TJ, Berenz A, Wicks J. The Economic Impact of Donor Milk in the Neonatal Intensive Care Unit. J Pediatr. 2020;224:57–65. Article  PubMed  PubMed Central  Google Scholar  * Richardson DK, Zupancic JAF, Escobar GJ, Ogino M, Pursley DM, Mugford M. A Critical Review of Cost Reduction in Neonatal Intensive Care I. The Structure of Costs. J Perinatol. 2001;21:107–15. Article  CAS  PubMed  Google Scholar  Download references ACKNOWLEDGEMENTS Fees incurred for analysis of costs were kindly waived by the finance departments of Sinai Health and The Hospital for Sick Children. FUNDING This work was funded by the Canadian Institutes of Health Research by a grant to SU, DO and AK (CIHR FDN 143233). CIHR had no role in the design and conduct of the study. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Pediatrics, Sinai Health, Toronto, ON, Canada Telford Yeung, Deborah L. O’Connor & Sharon Unger * Section of Neonatology, Windsor Regional Hospital, Windsor, ON, Canada Telford Yeung * Neonatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Asaph Rolnitsky * Department of Pediatrics, University of Toronto, Toronto, ON, Canada Asaph Rolnitsky & Sharon Unger * Translational Medicine Program, The Hospital for Sick Children, Toronto, ON, Canada Nicole Bando & Deborah L. O’Connor * Department of Nutritional Sciences, University of Toronto, Toronto, ON, Canada Susan Trang, Deborah L. O’Connor & Sharon Unger * System Funding and Analytics, Sinai Health, Toronto, ON, Canada Andy Geer * Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada Alex Kiss * Institute for Clinical Evaluative Sciences, Toronto, ON, Canada Alex Kiss Authors * Telford Yeung View author publications You can also search for this author inPubMed Google Scholar * Asaph Rolnitsky View author publications You can also search for this author inPubMed Google Scholar * Nicole Bando View author publications You can also search for this author inPubMed Google Scholar * Susan Trang View author publications You can also search for this author inPubMed Google Scholar * Andy Geer View author publications You can also search for this author inPubMed Google Scholar * Alex Kiss View author publications You can also search for this author inPubMed Google Scholar * Deborah L. O’Connor View author publications You can also search for this author inPubMed Google Scholar * Sharon Unger View author publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS The study design was conducted by TY, AR, NB, ST, DOC and SU. Data analysis was performed by TY, AR, AG, and AK. The manuscript was prepared by TY and critically edited by AR, NB, ST, AK, DOC, and SU. CORRESPONDING AUTHOR Correspondence to Sharon Unger. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. ETHICS APPROVAL This study was performed in accordance with the Declaration of Helsinki. Research ethics approval was obtained from Mount Sinai Hospital (REB number 14-0044-A) and The Hospital for Sick Children (REB number 1000063564). ADDITIONAL INFORMATION PUBLISHER’S NOTE Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. SUPPLEMENTARY INFORMATION SUPPLEMENTAL DATA RIGHTS AND PERMISSIONS Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Yeung, T., Rolnitsky, A., Bando, N. _et al._ A comparison of tertiary level NICU costs for infants born <1250 g supplemented with human versus bovine milk-based fortifiers. _J Perinatol_ 43, 1113–1118 (2023). https://doi.org/10.1038/s41372-023-01677-6 Download citation * Received: 21 December 2022 * Revised: 22 March 2023 * Accepted: 12 April 2023 * Published: 21 April 2023 * Issue Date: September 2023 * DOI: https://doi.org/10.1038/s41372-023-01677-6 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative

ABSTRACT BACKGROUND Human milk-based fortifiers (HMBF) are more costly than bovine milk-based fortifiers (BMBF); but, the efficacy of human or bovine fortification for infants born <1250 


g has yet to be fully elucidated. Our objective was to determine the effect of fortifier source on tertiary neonatal costs. METHODS Costs associated with tertiary neonatal care, including


direct and indirect hospital expenditures, feed-related costs and physician billing were analysed retrospectively for participants of OptiMoM (NCT02137473), a blinded RCT comparing fortifier


type for babies born <1250 g. A generalized linear model of cost according to fortifier type was created. RESULTS Mean [95% confidence interval] daily costs per patient, adjusted for


birth gestation and weight, was significantly greater in the human than the BMBF group ($3,452 [$3,186 – $3,740] Canadian dollars (CAD) versus $2,451 [$2,257 – $2,662] CAD) respectively, _p_


 < 0.0001). CONCLUSION HMBF usage entails additional costs on NICU stay that should be considered with implementation. Access through your institution Buy or subscribe This is a preview


of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only


$21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout


ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS HUMAN MILK-DERIVED FORTIFIERS


ARE LINKED WITH FEED EXTENSION DUE TO HYPOGLYCEMIA IN INFANTS <1250 G OR <30 WEEKS: A MATCHED RETROSPECTIVE CHART REVIEW Article 29 March 2023 IMMEDIATE FORTIFICATION OF HUMAN MILK


WITH A BOVINE MILK-DERIVED HUMAN MILK FORTIFIER IN VERY LOW BIRTH WEIGHT INFANTS: A RANDOMIZED CLINICAL TRIAL Article Open access 09 May 2024 DONOR HUMAN MILK VERSUS INFANT FORMULA FOR


LOW-RISK INFANTS: A SYSTEMATIC REVIEW Article Open access 06 June 2024 DATA AVAILABILITY The datasets generated during and/or analysed during the current study are not publically available


due to a risk for breeching patient confidentiality but may be available from the corresponding author on reasonable request. REFERENCES * Parker MG, Stellwagen LM, Noble L, Kim JH,


Poindexter BB, Puopolo KM. Section on Breastfeeding, Committee on Nutrition, Committee on Fetus and Newborn. Promoting human milk and breastfeeding for the very low birth weight infant.


Pediatrics 2021;148:e2021054272. Article  PubMed  Google Scholar  * Brown JVE, Embleton ND, Harding JE, McGuire W. Multi-nutrient fortification of human milk for preterm infants. Cochrane


Database Syst Rev. 2016;5:CD000343. Google Scholar  * Sandhu A, Fast S, Bonnar K, Baier FJ, Narvey M. Human based Human milk fortifier as Rescue Therapy in Very Low Birth Weight Infants


Demonstrating Intolerance to Bovine-Based Human Milk Fortifier. Breastfeed Med. 2017;12:570–3. Article  PubMed  PubMed Central  Google Scholar  * Quigley M, Embleton N, McGuire W. Formula


versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev. 2019;7:CD002971. PubMed  Google Scholar  * Premkumar MH, Pammi M, Suresh G. Human Milk


Derived Fortifier versus Bovine Milk Derived Fortifier for Prevention of Morbidity and Mortality in Preterm Neonates. Cochrane Database Syst Rev. 2019;11:CD013145. Google Scholar  * Sullivan


S, Schanler RJ, Kim JH, Patel AL, Trawöger R, Kiechl-Kohlendorfer U, et al. An Exclusively Human Milk-Based Diet is Associated with a Lower Rate of Necrotizing Enterocolitis Than a Diet of


Human Milk and Bovine-milk Based Products. J Pediatr. 2010;156:562–7. Article  CAS  PubMed  Google Scholar  * Hair AB, Peluso AM, Hawthorne KM, Perez J, Smith DP, Khan JY, et al. Beyond


Necrotizing Enterocolitis Prevention: Improving Outcomes with an Exclusive Human Milk-Based Diet. Breastfeed Med. 2016;11:70–5. Article  PubMed  PubMed Central  Google Scholar  * Herrmann K,


Carroll K. An Exclusive Human Milk Diet Reduces Necrotizing Enterocolitis. Breastfeed Med. 2014;9:184–90. Article  PubMed  PubMed Central  Google Scholar  * Assad M, Elliot MJ, Abraham JH.


Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36:216–20. Article  CAS  PubMed  Google Scholar  * O’Connor DL, Kiss A,


Tomlinson C, Bando N, Bayliss A, Campbell DM, et al. Nutrient enrichment of human milk with human and bovine milk-based fortifiers for infants born weighing <1250 g: a randomized clinical


trial. Am J Clin Nutr. 2018;108:108–16. Article  PubMed  Google Scholar  * Ganapathy V, Hay JW, Kim JH. Costs of Necrotizing Enterocolitis and Cost-Effectiveness of Exclusively Human


Milk-Based Products in Feeding Extremely Premature Infants. Breastfeed Med. 2011;6:1–9. Google Scholar  * Zupancic JAF, Richardson DK, O’Brien BJ, Schmidt B, Weinstein MC. Daily Cost


Prediction Model in Neonatal Intensive Care. Int J Technol Assess Health Care. 2003;19:330–8. Article  PubMed  Google Scholar  * Petrou S, Davidson LL. Economic issues in the follow-up of


neonates. Semin Neonatol. 2000;5:159–69. Article  CAS  PubMed  Google Scholar  * Ontario Ministry of Health and Long Term Care. Schedule of Benefits Physician Services under the Health


Insurance Act, 2015. Available at: www.health.gov.on.ca/en/pro/programs/ohip/sob. * Trang S, Zupancic JA, Unger S, Kiss A, Bando N, Wong S, et al. Cost-effectiveness of Supplemental Donor


Milk Versus Formula for Very Low Birth Weight Infants. Pediatrics. 2018;141:1–10. Article  Google Scholar  * CANSIM table 18-10-0005-01: Consumer price index, annual average, not seasonally


adjusted. 2019. Statistics Canada. Available at: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1810000501. * de Souza RJ, Eisen RB, Perera S, Bantoto B, Bawor M, Dennis BB, et al.


Best (but oft-forgetten) practices: sensitivity analysis in randomized controlled trials. Am J Clin Nutr. 2016;103:5–17. Article  PubMed  Google Scholar  * SAS statistics for Windows


[software], Version 9.4. Cary, NC. SAS Institute; Released 2013. https://documentation.sas.com/doc/en/pgmsascdc/9.4_3.5/whatsnew/titlepage.htm. * R Core Team (2020). R: A language and


environment for statistical computing. R Foundation for statistical computing, Vienna, Austria. URL https://www.R-project.org/. * Johnson TJ, Berenz A, Wicks J. The Economic Impact of Donor


Milk in the Neonatal Intensive Care Unit. J Pediatr. 2020;224:57–65. Article  PubMed  PubMed Central  Google Scholar  * Richardson DK, Zupancic JAF, Escobar GJ, Ogino M, Pursley DM, Mugford


M. A Critical Review of Cost Reduction in Neonatal Intensive Care I. The Structure of Costs. J Perinatol. 2001;21:107–15. Article  CAS  PubMed  Google Scholar  Download references


ACKNOWLEDGEMENTS Fees incurred for analysis of costs were kindly waived by the finance departments of Sinai Health and The Hospital for Sick Children. FUNDING This work was funded by the


Canadian Institutes of Health Research by a grant to SU, DO and AK (CIHR FDN 143233). CIHR had no role in the design and conduct of the study. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS *


Department of Pediatrics, Sinai Health, Toronto, ON, Canada Telford Yeung, Deborah L. O’Connor & Sharon Unger * Section of Neonatology, Windsor Regional Hospital, Windsor, ON, Canada


Telford Yeung * Neonatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada Asaph Rolnitsky * Department of Pediatrics, University of Toronto, Toronto, ON, Canada Asaph Rolnitsky 


& Sharon Unger * Translational Medicine Program, The Hospital for Sick Children, Toronto, ON, Canada Nicole Bando & Deborah L. O’Connor * Department of Nutritional Sciences,


University of Toronto, Toronto, ON, Canada Susan Trang, Deborah L. O’Connor & Sharon Unger * System Funding and Analytics, Sinai Health, Toronto, ON, Canada Andy Geer * Institute of


Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada Alex Kiss * Institute for Clinical Evaluative Sciences, Toronto, ON, Canada Alex Kiss Authors * Telford


Yeung View author publications You can also search for this author inPubMed Google Scholar * Asaph Rolnitsky View author publications You can also search for this author inPubMed Google


Scholar * Nicole Bando View author publications You can also search for this author inPubMed Google Scholar * Susan Trang View author publications You can also search for this author


inPubMed Google Scholar * Andy Geer View author publications You can also search for this author inPubMed Google Scholar * Alex Kiss View author publications You can also search for this


author inPubMed Google Scholar * Deborah L. O’Connor View author publications You can also search for this author inPubMed Google Scholar * Sharon Unger View author publications You can also


search for this author inPubMed Google Scholar CONTRIBUTIONS The study design was conducted by TY, AR, NB, ST, DOC and SU. Data analysis was performed by TY, AR, AG, and AK. The manuscript


was prepared by TY and critically edited by AR, NB, ST, AK, DOC, and SU. CORRESPONDING AUTHOR Correspondence to Sharon Unger. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no


competing interests. ETHICS APPROVAL This study was performed in accordance with the Declaration of Helsinki. Research ethics approval was obtained from Mount Sinai Hospital (REB number


14-0044-A) and The Hospital for Sick Children (REB number 1000063564). ADDITIONAL INFORMATION PUBLISHER’S NOTE Springer Nature remains neutral with regard to jurisdictional claims in


published maps and institutional affiliations. SUPPLEMENTARY INFORMATION SUPPLEMENTAL DATA RIGHTS AND PERMISSIONS Springer Nature or its licensor (e.g. a society or other partner) holds


exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely


governed by the terms of such publishing agreement and applicable law. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Yeung, T., Rolnitsky, A., Bando, N. _et al._ A comparison


of tertiary level NICU costs for infants born <1250 g supplemented with human versus bovine milk-based fortifiers. _J Perinatol_ 43, 1113–1118 (2023).


https://doi.org/10.1038/s41372-023-01677-6 Download citation * Received: 21 December 2022 * Revised: 22 March 2023 * Accepted: 12 April 2023 * Published: 21 April 2023 * Issue Date:


September 2023 * DOI: https://doi.org/10.1038/s41372-023-01677-6 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a


shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative